Blends
BPC-157 + TB-500
Also known as Wolverine blend
Here, BPC-157 and TB-500 share one vial in a 1:1 ratio. What science exists looks at the two peptides on their own, so the notes below cover each one individually and say nothing about how they might behave together.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- In the vial
- BPC-157 + TB-500
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 20 mg, lot BPCTB20-0803: 99.78% purity (RP-HPLC), 10.73 mg / 10.94 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7621
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Animal models of tendon, ligament and muscle damage
- Bone repair in animals
- Detection methods and breakdown products for drug testing
- Lab assays of how cells move and close gaps
How it is thought to work
BPC-157: Nobody has pinned down how it acts. TB-500: The parent molecule, thymosin beta-4, is a 43-residue protein that holds onto actin.
Where the research stands
Blend of research compounds. Each component is studied separately; as a combined vial it has no dedicated published research. The least-established component is BPC-157: mostly animal and cell work.
Sources
- Vasireddi N, et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal.
- McGuire FP, et al. (2025). Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current Reviews in Musculoskeletal Medicine.
- Esposito S, et al. (2012). Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Testing and Analysis.
- Ho EN, et al. (2012). Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry. Journal of Chromatography A.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.